192 related articles for article (PubMed ID: 24859605)
1. Effects of methoxsalen, a CYP2A5/6 inhibitor, on nicotine dependence behaviors in mice.
Bagdas D; Muldoon PP; Zhu AZ; Tyndale RF; Damaj MI
Neuropharmacology; 2014 Oct; 85():67-72. PubMed ID: 24859605
[TBL] [Abstract][Full Text] [Related]
2. N-acetylcysteine decreased nicotine reward-like properties and withdrawal in mice.
Bowers MS; Jackson A; Maldoon PP; Damaj MI
Psychopharmacology (Berl); 2016 Mar; 233(6):995-1003. PubMed ID: 26676982
[TBL] [Abstract][Full Text] [Related]
3. New insights on the effects of varenicline on nicotine reward, withdrawal and hyperalgesia in mice.
Bagdas D; Alkhlaif Y; Jackson A; Carroll FI; Ditre JW; Damaj MI
Neuropharmacology; 2018 Aug; 138():72-79. PubMed ID: 29860196
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of nicotine metabolism by methoxysalen: Pharmacokinetic and pharmacological studies in mice.
Damaj MI; Siu EC; Sellers EM; Tyndale RF; Martin BR
J Pharmacol Exp Ther; 2007 Jan; 320(1):250-7. PubMed ID: 17021260
[TBL] [Abstract][Full Text] [Related]
5. The role of alpha6-containing nicotinic acetylcholine receptors in nicotine reward and withdrawal.
Jackson KJ; McIntosh JM; Brunzell DH; Sanjakdar SS; Damaj MI
J Pharmacol Exp Ther; 2009 Nov; 331(2):547-54. PubMed ID: 19644040
[TBL] [Abstract][Full Text] [Related]
6. Effects of orally-bioavailable short-acting kappa opioid receptor-selective antagonist LY2456302 on nicotine withdrawal in mice.
Jackson KJ; Jackson A; Carroll FI; Damaj MI
Neuropharmacology; 2015 Oct; 97():270-4. PubMed ID: 26044637
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic and pharmacodynamics studies of nicotine after oral administration in mice: effects of methoxsalen, a CYP2A5/6 inhibitor.
Alsharari SD; Siu EC; Tyndale RF; Damaj MI
Nicotine Tob Res; 2014 Jan; 16(1):18-25. PubMed ID: 23884323
[TBL] [Abstract][Full Text] [Related]
8. Attenuation by baclofen of nicotine rewarding properties and nicotine withdrawal manifestations.
Varani AP; Aso E; Moutinho LM; Maldonado R; Balerio GN
Psychopharmacology (Berl); 2014 Aug; 231(15):3031-40. PubMed ID: 24553576
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological modulation of the α7 nicotinic acetylcholine receptor in a mouse model of mecamylamine-precipitated nicotine withdrawal.
Jackson A; Papke RL; Damaj MI
Psychopharmacology (Berl); 2018 Jul; 235(7):1897-1905. PubMed ID: 29549391
[TBL] [Abstract][Full Text] [Related]
10. Both nicotine reward and withdrawal are enhanced in a rodent model of diabetes.
Pipkin JA; Cruz B; Flores RJ; Hinojosa CA; Carcoba LM; Ibarra M; Francis W; Nazarian A; O'Dell LE
Psychopharmacology (Berl); 2017 May; 234(9-10):1615-1622. PubMed ID: 28342091
[TBL] [Abstract][Full Text] [Related]
11. The β3 subunit of the nicotinic acetylcholine receptor is required for nicotine withdrawal-induced affective but not physical signs or nicotine reward in mice.
Jackson AB; Toma W; Contreras KM; Alkhlaif Y; Damaj MI
Pharmacol Biochem Behav; 2019 Aug; 183():1-5. PubMed ID: 31145916
[TBL] [Abstract][Full Text] [Related]
12. L-theanine attenuates nicotine reward and withdrawal signs in mice.
Alkhlaif Y; El-Halawany M; Toma W; Park A; Hamouda AK; Damaj MI
Neurosci Lett; 2023 Jun; 807():137279. PubMed ID: 37105354
[TBL] [Abstract][Full Text] [Related]
13. Mecamylamine elicits withdrawal-like signs in rats following a single dose of nicotine.
Harris AC; Manbeck KE; Schmidt CE; Shelley D
Psychopharmacology (Berl); 2013 Jan; 225(2):291-302. PubMed ID: 22868410
[TBL] [Abstract][Full Text] [Related]
14. Reward sensitization: effects of repeated nicotine exposure and withdrawal in mice.
Hilario MR; Turner JR; Blendy JA
Neuropsychopharmacology; 2012 Nov; 37(12):2661-70. PubMed ID: 22828747
[TBL] [Abstract][Full Text] [Related]
15. Preadolescent tobacco smoke exposure leads to acute nicotine dependence but does not affect the rewarding effects of nicotine or nicotine withdrawal in adulthood in rats.
Yamada H; Bishnoi M; Keijzers KF; van Tuijl IA; Small E; Shah HP; Bauzo RM; Kobeissy FH; Sabarinath SN; Derendorf H; Bruijnzeel AW
Pharmacol Biochem Behav; 2010 Jun; 95(4):401-9. PubMed ID: 20211642
[TBL] [Abstract][Full Text] [Related]
16. Lack of GABAB receptors modifies behavioural and biochemical alterations induced by precipitated nicotine withdrawal.
Varani AP; Pedrón VT; Machado LM; Antonelli MC; Bettler B; Balerio GN
Neuropharmacology; 2015 Mar; 90():90-101. PubMed ID: 25479464
[TBL] [Abstract][Full Text] [Related]
17. The cannabinoid CB2 receptor is necessary for nicotine-conditioned place preference, but not other behavioral effects of nicotine in mice.
Ignatowska-Jankowska BM; Muldoon PP; Lichtman AH; Damaj MI
Psychopharmacology (Berl); 2013 Oct; 229(4):591-601. PubMed ID: 23652588
[TBL] [Abstract][Full Text] [Related]
18. The role of pituitary adenylyl cyclase activating polypeptide in affective signs of nicotine withdrawal.
Nega S; Marquez P; Hamid A; Ahmad SM; Lutfy K
J Neurosci Res; 2020 Aug; 98(8):1549-1560. PubMed ID: 32476165
[TBL] [Abstract][Full Text] [Related]
19. Characterization of spontaneous and precipitated nicotine withdrawal in the mouse.
Damaj MI; Kao W; Martin BR
J Pharmacol Exp Ther; 2003 Nov; 307(2):526-34. PubMed ID: 12970387
[TBL] [Abstract][Full Text] [Related]
20. Effects of the beta-lactam antibiotic ceftriaxone on nicotine withdrawal and nicotine-induced reinstatement of preference in mice.
Alajaji M; Bowers MS; Knackstedt L; Damaj MI
Psychopharmacology (Berl); 2013 Aug; 228(3):419-26. PubMed ID: 23503685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
